The afi T-cell receptor (TCR) recognizes antigenic peptides bound to major histocompatibility complex (MHC) molecules. In contrast to the antibody combining site, for which the antigen contact or complementarity-determining residues (CDRs) have been precisely defined, the location and function of the corresponding CDR regions of the a and (3 TCR chains are not known. To develop a model system for systematic analysis of the CDRs of the af TCR, we isolated a panel of murine T-cell clones that recognize a lysozyme peptide containing residues 74-88 bound to either A" or Abt-I2 MHC class II molecules. Although these two MHC molecules differ by only three amino acid residues within the AP chain, each of the (14). By extrapolating the known structure of the antigen combining site of antibody molecules to the TCR combining site, the model suggests that residues within the V segments contact the MHC and residues within the CDR3 regions contact the antigen. Whereas changes in the ligand specificity ofTCRs do correlate with amino acid substitutions within the V(D)J regions (where D is diversity and J isjoining) of the a and f3 chains, the role of the Va/V/ segments and of the MHC molecules in determining these effects is not known (6, 15) .
only three amino acid residues within the AP chain, each of the T-cell clones was specific for peptide bound to the self-MHC molecule and did not rpcognize the same peptide bound to the other MHC molecule. The structural basis for this exquisite ligand specificity of the TCRs was analyzed by isolation and characterization of a and (3 chain genes from five closely related T-cell clones. Comparison of predicted amino acid sequences mapped the ligand specificity differences to residues present within the a chain variable region segment and the a and (3 chain variable-joining region junction regions. Thus with current models of TCR-ligand interactions, the results suggest that residues 26-30 of the a chain variable region may constitute one of the CDR regions of the TCR.
The unique ligand specificity of the T-cell receptor (TCR) for peptides bound to major histocompatibility complex (MHC) molecules is the basis for selection of self-MHC-restricted T cells in the thymus and for MHC-restricted antigen recognition by mature T cells (1) (2) (3) . Comparison of the a and f TCR chains with their antibody heavy and light chain counterparts has revealed similarities in genomic organization of gene segments encoding these polypeptides, in genetic mechanisms that give rise to structural diversity, and in conservation of many amino acid residues at identical positions (4, 5) . These common features suggest that the TCR and the antibody combining sites are closely related in structure and function. However, unlike the antibody molecule, the TCR does not directly bind to the antigen and its ligand combining site is likely to contact residues ofboth antigenic peptides and the MHC molecule. The precise location of these complementarity-determining residues (CDRs) of the TCR is not known.
Direct gene transfer studies as well as comparison of primary amino acid sequences of a and l3 chains derived from TCRs with defined antigenic specificities have suggested that variable (V) regions of both chains contribute to ligand specificity (for review, see ref. 6) . Several exceptions are known, however, where ligand specificity strongly correlates with the utilization of a particular TCR l3 chain V region (V13) and, occasionally, of a chain V region (Va) segments (7) (8) (9) (10) (11) (12) . An essentially similar model has been proposed independently by Davis and Bjorkman (13) and by Chothia et al. (5) to explain the structural relationship between the af TCR combining site with the antigen-MHC ligand recognition function. This model was prompted by solution of the crystal structure of the class I MHC molecule that revealed the location of the polymorphic residues within the MHC molecules as lining the antigen binding groove on the top surface of the molecule (14) . By extrapolating the known structure of the antigen combining site of antibody molecules to the TCR combining site, the model suggests that residues within the V segments contact the MHC and residues within the CDR3 regions contact the antigen. Whereas changes in the ligand specificity ofTCRs do correlate with amino acid substitutions within the V(D)J regions (where D is diversity and J isjoining) of the a and f3 chains, the role of the Va/V/ segments and of the MHC molecules in determining these effects is not known (6, 15) .
In this report, we describe the development of a model system to systematically test the structure-function relationship of the af3 TCR. We have generated a panel of T-cell clones that are specific for lysozyme peptides bound to either the Ab or the Abm-12 class II MHC molecules. These two MHC molecules differ only in three amino acids at positions 67, 70, and 71 of their AP3 subunits (16 (17) . Hen egg white lysozyme peptides corresponding to residues 74-96 (p74-96), NH2-Asn-Leu-Cys-Asn-Ile-Pro-Cys-Ser-Ala-Leu-Leu-Ser-SerAsp-Ile-Thr-Ala-Ser-Val-Asn-Cys-Ala-Lys-OH were prepared by solid-phase synthesis (17) .
Cell Culture. Methods for generation and maintenance of antigen-specific long-term T-cell lines or T-cell hybrids have been described (17 (19) and cloned with size-selected DNA (including the rearranged fragment) isolated from agarose gels as described (20) . The isolated clones were subjected to restriction enzyme analysis and appropriate fragments containing the VDJB sequences were subcloned into M13mpl8 vector and sequenced by the dideoxynucleotide chain-termination method (21) . Specific J,/ oligonucleotide primers and the universal M13 vector primer were used to sequence both strands of the clones.
Total cellular RNA was prepared from the T-cell hybrids and poly(A)+ RNA was isolated by two passes over oligo(dT)-cellulose (Collaborative Research, type 3). cDNA was synthesized from the poly(A)' RNA using avian myeloblastosis virus reverse transcriptase, RNase H, and Escherichia coli DNA polymerase I as described (22) . The cDNA fragments >1 kilobase were inserted into the AgtlO vector after addition of EcoRI linkers. The cDNA libraries were screened with murine Ca and C,3 probes, and positive clones were probed with Val and V,31 DNA fragments to eliminate clones derived from the BW5147 fusion partner (23, 24) . The EcoRI inserts of the AgtlO cDNA clones were isolated, subcloned into M13mpl8 vector, and sequenced as for, chain genes above with oligonucleotides specific for the 5' ends of Ca or CB and the universal M13 primers (23, 24) .
RESULTS AND DISCUSSION
Responsiveness of bm-12 Mice to p74-96. In our earlier studies with p74-96-specific T cells in C57BL/6 (B6) mice, two distinct lysozyme peptides containing residues 74-90 (p74-90) and 81-96 (p81-96) were identified as the major antigenic determinants recognized in the context of the A" MHC molecule (25, 26) . B6-C-H-2bm-12 (bm-12) mice express the Abm-12 MHC molecule, which differs from the Ab MHC molecule in only three amino acid residues at positions 67,70, and 71 of the Af3 chain. To assess the influence of the amino acid differences among Abm-12 and Ab molecules toward the antigen-specific T-cell response, bm-12 mice were immunized with p74-96. The antigen-specific proliferative response of draining lymph node cells and long-term T-cell lines derived from the B6 and bm-12 mice was tested with the immunogen and with smaller peptides (Table 1 ). Similar to B6 T cells, bm-12 T cells responded strongly to p74-96 and to p74-90. Furthermore, the minimal peptide determinant recognized by both B6 and bm-12 mice within p74-90 was similar in that truncation of the four C-terminal residues 87-90 in p74-86 abolished the antigen-specific response. However, unlike B6 mice, which also elicited T cells specific for p81-96, T cells with this specificity were not detected in bm-12 mice. Thus, the three amino acid substitutions between the two class II MHC molecules did not alter the ability of bm-12 mice to respond to the p74-90 but were, however, associated with the absence of p81-96-specific T cells in bm-12 mice.
Both B6 and bm-12 T-Cell Clones Recognize Similar Minimal Peptide Determinants. The finding that T cells with similar antigen specificity were induced in both B6 and bm-12 mice is in marked contrast to our earlier studies (17) . Comparison of T-cell responses induced by p74-96 had shown dramatic differences in the minimal peptide determinants recognized in the context of Ak (p74-82) or Ek (p85-96) class II MHC molecules. These differences were attributed to the extensive structural differences between the polymorphic MHC molecules (17) . To identify possible differences in the minimal peptide determinant(s) within p74-90 recognized by individual B6 and bm-12 T cells, additional synthetic peptides were tested with individual T-cell clones. Each of the four B6 and five bm-12 T-cell hybrids recognized p74-90, p74-89, and p74-88, demonstrating that the minimal antigenic determinants were contained within p74-88 (Table 2) . Because each of the clones failed to recognize p74-86, residues 87 and/or 88 were required for antigen recognition. The requirement for both residues 87 and 88 was, however, not absolute because B04T27.6, bmlT5.1, and bm4T17.2 T cells could also recognize p74-87. Furthermore, truncation of a single amino acid from the N-terminal end (p75-96) completely abolished peptide recognition by either B6 or bm-12 T-cell clones (data not shown). Thus, in contrast to the nonoverlapping peptides p74-82 vs. p85-96, which were presented Alternatively, the absence of p81-96-specific T cells could be due to an influence of these three residues on positive or negative selection of self-MHC reactive TCRs in the thymus (3). Nevertheless, existence ofp74-88-specific T cells in both B6 and bm-12 mice demonstrates that both Ab and Abm-12 molecules can both bind to the same peptide. Furthermore, the fact that each of the two sets of TCRs fails to cross-react between the peptide-bound Ab and Abm-12 molecules shows that these three residues do affect TCR-MHC interactions. The simplest interpretation of these results is that, for TCRs specific for p74-88, the interactions between the TCR and MHC include contacts with one or more of the three amino acid substitutions. However, more complex interpretations in which the lack of cross-reaction may be due to differences in conformation ofp74-88 when bound to Ab vs. Abm-12 MHC molecules cannot be dismissed.
Characterization of the ap TCRs of B6 and bm-12 T-Cefl Clones. To determine the structural basis for the ligand specificity of these T-cell clones, we analyzed their TCR a and p3 chains. We first isolated the rearranged genomic fragments containing the functional VaJa and VDJ(3 exons from T-cell hybrid B04H9.1. The nucleotide sequence of these V regions showed that the P and a chains, respectively, contained the VP3 and a member of the Vall subfamily ( Figs. 1 and 2 ). This Va segment, referred to as Vall.b, is identical to the Vall.3 segment derived from B1O.A mice (31), except for nine nucleotide substitutions that result in two amino acid replacements at positions -20 and 43 of the precursor polypeptide. Because these TCRs were derived from the B6 strain, it is not clear whether this Va segment is allelic to Vall.3 of B10 mice or whether it is a member of the Vall subfamily (39) . The V,83 and Vall.b fragments were used to screen Northern blots of nine B6 and eight bm-12 T-cell clones to identify other TCRs that also expressed these two V gene segments. From this analysis, one additional B6 (BO3H.25) and two bm-12 (bm2T3.1 and bm4T6.2) T-cell clones were identified that expressed transcripts hybridizing with both the Vf3 and Vall.b probes (see Fig. 2 ). By sequence analysis of rearranged genomic fragments, we also determined that B04T27.6, bmlT7.6, and bm4T17.2 TCRs contained the Vf36, V32, and Vf33 gene segments, respectively ( Fig. 2 and data not shown) TCTATCGCCGCGACACT GTGCAGTGGT TCCTACAGAATCCCAGGGGCAGCCTCATCAAT CT TT TTTACCTGGTTCCAGACAAAGGAGAATGGGAGGT TAG  T T NK (Fig. 1B) .
Comparison of nucleotide and predicted amino acid sequences encoding Va and V(3 chains expressed by the B6 and bm-12 clones showed that these TCRs are closely related (Figs. 1A and 2 ). Despite the fact that each of these T cells was isolated from different mice, BO3H.25 and B04H9.1 TCRs contained identical Vall.b segments joined to Ja33, with only a single Ala -* Gly substitution at the Va-Ja junction. Similarly, bm2T3.1 and bm4T6.2 TCRs used the same Vall.bm and Jal8 segments with only three residue differences (Glu-Ala-Asp to Asp-Met-Asn) at the Va-Ja junction. Each TCR contained the same VB3 segment with differences localized only to the JP and VDJ,8 junctions.
Again, both B6-and bm-12-derived TCRs used either the J,81.2 or the Jp2.6 gene segments. Furthermore, both bm-12
TCRs used identical ( chain polypeptides despite nucleotide sequence differences at the V-J junction. All three V,833 bm-12 TCRs used the same Jj32.6 segment. The repeated usage of the same J13 segments suggests that they serve an important function in determining the ligand specificity of these TCRs.
How do these af3 TCRs recognize the peptide-MHC complex? Among these two B6 and bm-12 sets of T cells, each specific for the same antigen p74-88 bound to either Ab or Abm-12 MHC molecules, at least five pairs of a and ,8 chains were expressed. Distinct TCR a and ,3 chain pairs that recognize the same peptide-MHC complex can be thought to bind the antigen-MHC ligand by three mechanisms. (i) Despite their apparent similarity, the antigen-MHC ligands (33) . The 3' boundary of VB3 segment is based on germ-line sequence (34) . The /3 chain cDNA sequence for BO3H.25 is identical to the published genomic sequence (34) . The N-J boundaries were determined by comparison to the germ-line sequences of Ja33 (28), Jal8 and Ja4O (B. Koop, R. Wilson, and L.H., unpublished data), JP1.2 (35) , and J,82.6 (36) . The N regions for the ,8 chains are indicated under the D.8 heading with the D3,81 (37) or D132 (38) germ-line sequences underlined. may be quite different. For example, the same p74-88 may bind to the antigen binding groove of the MHC molecules in more than one conformation and thus give rise to distinct ligand structures as hypothesized for the p52-61-Ak complex (27) . (ii) Even if a single stable conformation ofp74-88-MHC ligand exists, the TCRs may bind to distinct surfaces of the same ligand. In this context, it is interesting that different nonapeptides bound to the antigen binding site of human HLA-B27 class I MHC molecules appear to occupy a fixed orientation (40) . Whether the generally larger peptides such as the 15-residue p74-88 described here and those recently eluted from class II MHC molecules (41) will also occupy similar fixed positions within the antigen binding groove of class II MHC molecules is not known. (iii) A single ligand may be recognized by the TCRs in a similar orientation, and the combining sites formed by the distinct a and P chains may in fact be functionally equivalent. The first two possibilities predict that differences in af3 TCR structure are due to their different ligand specificities, whereas the third possibility predicts that, despite different primary sequences, functionally equivalent TCR combining sites may be generated. These three possibilities cannot be distinguished by sequence comparisons alone but are amenable to experimental test (42) .
Interestingly, four TCRs from B6 (BO3H.25 and B04H9.1) and bm-12 (bm2T3.1 and bm4T6.2) mice expressed the same V,33 segment with two members of the Vall subfamily. Furthermore, both pairs of B6 TCRs used the same JP1.2 and Ja33 segments and the bm-12 TCRs expressed the J/82.6 and Jal8 segments. The repeated occurrence of these segments in the TCRs is unlikely to be fortuitous because these TCRs were independently isolated. Also, these particular combinations of gene segments were not found among the random set of 178 B6 TCRs alloreactive to the Abm-l2 MHC molecules (43) . The differences in ligand specificity of these TCRs must, therefore, be accounted for by amino acid differences within V(-Jf3 junctions and a polypeptides. Extensive analysis of V segment usage among cytochrome-specific TCRs has shown that expression of Vall.1 or Vall.2 segments with alternative Vf8 segments correlates strongly with recognition of the cytochrome peptide by different alleles of the E class II MHC molecule (6, 9) . However, the fact that our TCRs clearly distinguish the Ab vs. Abm-l2 molecules and yet use identical V/33 segments shows that V13 segments do not by themselves play a major role in determining peptide or MHC (8 chain specificity of the TCRs. Instead our results point to the importance of other regions of a and (3 chains in determining ligand specificity.
Current models of TCR-ligand interactions suggest that contacts between the TCR and the MHC molecule primarily occur within residues of Va and VB segments, whereas residues within Ja, JP3, and junction regions contact the peptide antigen (5, 13) . Because the antigenic peptides recognized by all our TCRs are similar, application of these models to our TCRs predicts that differences within the Vall.b and Vall.bm segments would be associated with recognition of the MHCspecific differences. The Vall.b and Vall.bm segments of the mature polypeptides differ in 24 out of a total of 87 amino acids. Fourteen ofthese residues occur within the first 30 amino acids, and a contiguous cluster of 5 amino acid substitutions occurs at residues 26-30. Significantly, residues 28-34 and 31-35 of the antibody light and heavy chains, respectively, contain the first CDR region. Thus, it is attractive to postulate that this cluster defines one of the CDR regions of the Va segments. However, the importance of this cluster and of other regions of the TCR in determining the peptide-MHC specificity must await results of mutagenesis experiments.
